摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrol-1-yl]propanoylamino]ethyl]carbamate | 1446684-66-7

中文名称
——
中文别名
——
英文名称
[(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrol-1-yl]propanoylamino]ethyl]carbamate
英文别名
——
[(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrol-1-yl]propanoylamino]ethyl]carbamate化学式
CAS
1446684-66-7
化学式
C29H45N9O8
mdl
——
分子量
647.732
InChiKey
MBLSGYHBUDRPQJ-JHBZDSIHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.7
  • 重原子数:
    46
  • 可旋转键数:
    18
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    254
  • 氢给体数:
    7
  • 氢受体数:
    10

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    methyl 3-(2,5-dioxo-3-(9-oxodecyl)-2,5-dihydro-1H-pyrrol-1-yl)propanoate 在 N,N-二异丙基乙胺三丁基氧化锡 作用下, 以 aq. phosphate buffer 、 二氯甲烷甲苯乙腈 为溶剂, 反应 39.0h, 生成 [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrol-1-yl]propanoylamino]ethyl]carbamate
    参考文献:
    名称:
    Maleimide Conjugates of Saxitoxin as Covalent Inhibitors of Voltage-Gated Sodium Channels
    摘要:
    (+)-萨克霉素是一种天然存在的胍类毒素,用作电压门控钠离子通道(Na(V)s)的强效、选择性和可逆抑制剂。通过全合成得到的这种毒素的修饰形式带有半胱氨酸反应的马来酰亚胺基团,发现这些修饰形式不可逆地抑制了在重组表达的野生型钠离子通道和海马神经细胞中钠离子的传导。我们的发现支持了一种共价蛋白质修饰机制,其中毒素结合到通道孔道先于马来酰亚胺对亲核氨基酸的烷基化。还包括生物正交反应基团的第二代马来酰亚胺毒素缀合物也被发现不可逆地阻断了通道功能;此类化合物在选择性标记钠离子通道(用于活细胞成像和/或蛋白质组学实验)的试剂方面具有潜在用途。
    DOI:
    10.1021/ja4019644
点击查看最新优质反应信息

文献信息

  • Maleimide Conjugates of Saxitoxin as Covalent Inhibitors of Voltage-Gated Sodium Channels
    作者:William H. Parsons、J. Du Bois
    DOI:10.1021/ja4019644
    日期:2013.7.24
    (+)-Saxitoxin, a naturally occurring guanidinium poison, functions as a potent, selective, and reversible inhibitor of voltage-gated sodium ion channels (Na(V)s). Modified forms of this toxin bearing cysteine-reactive maleimide groups are available through total synthesis and are found to irreversibly inhibit sodium ion conductance in recombinantly expressed wild-type sodium channels and in hippocampal nerve cells. Our findings support a mechanism for covalent protein modification in which toxin binding to the channel pore precedes maleimide alkylation of a nucleophilic amino acid. Second-generation maleimide-toxin conjugates, which include bioorthogonal reactive groups, are also found to block channel function irreversibly; such compounds have potential as reagents for selective labeling of Na(V)s for live cell imaging and/or proteomics experiments.
    (+)-萨克霉素是一种天然存在的胍类毒素,用作电压门控钠离子通道(Na(V)s)的强效、选择性和可逆抑制剂。通过全合成得到的这种毒素的修饰形式带有半胱氨酸反应的马来酰亚胺基团,发现这些修饰形式不可逆地抑制了在重组表达的野生型钠离子通道和海马神经细胞中钠离子的传导。我们的发现支持了一种共价蛋白质修饰机制,其中毒素结合到通道孔道先于马来酰亚胺对亲核氨基酸的烷基化。还包括生物正交反应基团的第二代马来酰亚胺毒素缀合物也被发现不可逆地阻断了通道功能;此类化合物在选择性标记钠离子通道(用于活细胞成像和/或蛋白质组学实验)的试剂方面具有潜在用途。
查看更多

同类化合物

苯丙腈,b-氟-a-羟基- 膝沟藻毒素4 膝沟藻毒素 VIII 膝沟藻毒素 V 膝沟藻毒素 III 膝沟藻毒素 II 膝沟藻毒素 I 去氨基甲酰石房蛤毒素 原膝沟藻毒素4 二乙酸贝毒素 {2-[(3aS,4R,6Z)-2-氨基-5,10,10-三羟基-6-亚氨基-9-(磺基氧基)-3a,4,5,6-四氢-3H,10H-吡咯并[1,2-c]嘌呤-4-基]-1,1-二羟基乙基}氨基磺酸 (3As,10As)-3Aa,4,9,10-四氢-2,6-二氨基-4a-[[(磺基氨基羰基)氧基]甲基]-1H,8H-吡咯并[1,2-c]嘌呤-9b,10,10-三醇 9-硫酸酯 GTX 3 Atelopidtoxin ((3aS,4R,10aS)-10,10-dihydroxy-2,6-diiminooctahydro-1H,8H-pyrrolo[1,2-c]purin-4-yl)methyl (2-aminoethyl)carbamate (3aS,4R,10S,10aR)-tert-butyl 2,6-bis((tert-butoxycarbonyl)imino)-4-((carbamoyloxy)methyl)-10-hydroxyoctahydropyrrolo[1,2-c]purine-1(8H)-carboxylate [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrol-1-yl]propanoylamino]ethyl]carbamate [(3aS,4R,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl N-[2-[3-[2,5-dioxo-3-(9-oxodecyl)pyrrolidin-1-yl]propanoylamino]ethyl]carbamate [2,6-diamino-4-[(1-amino-3-methyl-2-oxo-6-prop-1-en-2-ylcyclohex-3-en-1-yl)oxymethyl]-10,10-dihydroxy-3a,4,8,9-tetrahydro-3H-pyrrolo[1,2-c]purin-9-yl] hydrogen sulfate N-Sulfocarbamoylgonyautoxin 2 decarbamoyl-α-saxitoxinol [(3aS,4R,9S,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-3H-pyrrolo[1,2-c]purin-9-yl] hydrogen sulfate ditert-butyl (3aS,4R,10S,10aR)-4-[(4-methoxyphenyl)methoxymethyl]-2,6-bis[(2-methylpropan-2-yl)oxycarbonylimino]-3-methylsulfonyl-10-trimethylsilyloxy-4,8,9,10-tetrahydro-3aH-pyrrolo[1,2-c]purine-1,5-dicarboxylate [(3aS,4R,10S,10aS)-2,6-diamino-10-hydroxy-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl N-(6-aminohexyl)carbamate [(3aS,4R,9S,10R,10aS)-9,10-dihydroxy-6-[(2,2,2-trichloroacetyl)amino]-2-(2,2,2-trichloroethoxysulfonylamino)-1,3a,4,8,9,10-hexahydropyrrolo[1,2-c]purin-4-yl]methyl carbamate (2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl N-[6-[4-[4-[2-[4-cyano-5-(dicyanomethylidene)-2,2-dimethylfuran-3-yl]ethenyl]-N-methylanilino]butanoylamino]hexyl]carbamate [(3aR,4R,9R,10aR)-2,6-diamino-10,10-dihydroxy-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate [(3aS,4R,9R,10aR)-2,6-diamino-10,10-dihydroxy-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methoxycarbonylsulfamic acid [(3aS,4S,10aS)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate [(3aS,4R,9S,10aS)-2,6-diamino-10,10-dihydroxy-4-(hydroxymethyl)-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl] 4-(trifluoromethyl)benzoate 5-[6-[(2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methoxycarbonylamino]hexylcarbamoyl]-2-(2,7-difluoro-3-hydroxy-6-oxoxanthen-9-yl)benzoic acid (2-amino-10,10-dihydroxy-6-pentylimino-1,3a,4,5,8,9-hexahydropyrrolo[1,2-c]purin-4-yl)methyl N-(6-aminohexyl)carbamate (2,6-diamino-1,9,10-trihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl N-(3,4-dimethylpentan-2-yl)carbamate (2,6-diamino-1,10-dihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl N-[6-[6-(hexylamino)hexanoylamino]hexyl]carbamate (2,6-diamino-1,10-dihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl N-[6-[[6-(7-methyloctylamino)-6-oxohexanoyl]amino]hexyl]carbamate Saxitoxin p-bromobenzenesulfonate [(3aS,4R)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate alpha-Saxitoxinol (3aS)-2,6-diamino-4-methyl-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purine-10,10-diol [(3aS,4R,9R,10aS)-2-amino-5,10,10-trihydroxy-4-(hydroxymethyl)-6-imino-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-9-yl] hydrogen sulfate [(3aS,4R,9R)-2-amino-5,10,10-trihydroxy-6-imino-9-sulfooxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate (2,6-diamino-1,10-dihydroxy-10-methyl-2,3,3a,4,8,9-hexahydropyrrolo[1,2-c]purin-4-yl)methyl N-propan-2-ylcarbamate (2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl N-[4-(2,5-dioxopyrrol-1-yl)phenyl]carbamate (2,6-diamino-1-hydroxy-10-methoxy-4,8,9,10-tetrahydro-3aH-pyrrolo[1,2-c]purin-4-yl)methyl N-propan-2-ylcarbamate (2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl)methyl N-[[4-[4-(4-methylpentan-2-ylcarbamoyl)benzoyl]phenyl]methyl]carbamate [(4R)-2,6-diamino-10,10-dihydroxy-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate (2,6-Diamino-1,9,10-trihydroxy-10-methyl-3a,4,8,9-tetrahydropyrrolo[1,2-c]purin-4-yl)methyl carbamate gonyautoxin VI (2,6-diamino-10,10-dihydroxy-5-oxido-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-5-ium-4-yl)methyl carbamate [(3aS,4R,10aS)-2-amino-5,10,10-trihydroxy-6-imino-3a,4,8,9-tetrahydro-1H-pyrrolo[1,2-c]purin-4-yl]methyl carbamate